Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on TECNICAS REUNIDAS SA. We currently have 6 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
TECNICAS REUNIDAS SA
TECNICAS REUNIDAS SA
Confident on the outlook for 2017
10 Nov 16
Q3 revenues were €1.13bn (+1% yoy); EBIT came in at €47m (-13% yoy), slightly above consensus estimates, and a 4.0% margin (80bp lower than in Q3 15). Net profit was €35m (-12% yoy), in line with consensus. The order intake was €0.5bn in Q3 (vs. €1.8bn in Q3 15). Guidance for 2016 raised: - sales at €4.5-4.6bn (vs. €4.3-4.6bn previously); - EBIT margin at around 4%.
Guidance 2016 confirmed and all projects on track
29 Jul 16
Q2 revenues came in at €1.25bn (+28% yoy); EBIT was €50m, flat yoy, and a 4.0% margin (110bp lower than Q2 15), in line with expectations. Net profit was €36m (-3% yoy), broadly in line with our estimate but somewhat above consensus. There were no significant contracts in Q2 and the backlog stood at €10.65bn (+18% yoy). Guidance 2016 confirmed: - Sales at €4.3-4.6bn; - EBIT margin at around 4%.
Backlog execution on track; guidance 2016 confirmed
13 May 16
Q1 revenues were €1.1bn (+16% yoy), in line with consensus estimates. The operating profit came in at €42m (-7% yoy), also in line with consensus, while the net profit, at €30m, was slightly below expectations (at €32m). The order intake was €1.0bn and the backlog stood at €12.0bn (+42% yoy). Guidance 2016 confirmed: - Sales at €4.3-4.6bn; - EBIT margin at around 4%.
Robust backlog supports 2016, despite low EBIT margin
01 Mar 16
Q4 15 has been a negative surprise, despite revenue growth at +39% yoy, to €1.2bn, and a backlog at record levels of €12.1bn (+44% yoy), o/w >60% is in the Middle East. The disappointment comes from one-off incremental costs related to a project in Alberta (Canadian Natural Resources Limited is the client). As a result, the company in the quarter posted a €62m loss at the EBIT level (vs. €42m positive EBIT in Q4 14), and a €55m net loss (vs. €36m net profit in Q4 14), bringing the net profit 2015 down to €60m. Guidance 2016: - Sales at €4.3-4.6bn; - EBIT margin at around 4%.
Q3 positive surprise; orders keep coming while cash inflows take longer
13 Nov 15
Q3 revenues were up 37% yoy, to €1,122m, well above consensus expectations. The backlog stood at €10bn (+14% yoy). EBIT grew by 30%, to €53m (4.8% margin, as in Q2 14), above consensus estimates. Net profit was €40m (+21% yoy), 8% above consensus estimates. In Q3, the company booked the order for the Al Zour refinery in Kuwait (for KNPC). Q4 qtd order intake: 1) EPC contract for Sasol in Louisiana: €150m over 2.5 years; 2) EPC and pre-commissioning for production facilities in Abu Dhabi (ADOC): lump sum turnkey, $310m in less than two years. Net cash was €348m, 47% below last year, reflecting lower advanced payments in more recent projects and longer contract milestones in some large projects being executed.
Q2 15 results, growing Kuwait footprint
31 Jul 15
Q2 revenues were up 30% yoy, to €978m, thanks to the high backlog (at €9bn, +16% yoy) and above consensus expectations. EBIT grew by 32%, to €50m (5.1% margin, as in Q2 14). Net profit was €37m (+9% yoy), slightly above consensus estimates. The order intake in Q2 15 was €1.3bn (EPC for the execution of the fifth Gas Train (GT5) at Mina al-Ahmadi Refinery in Kuwait); the backlog stood at €9bn (+15% yoy), 95% in Oil & Gas. Net cash was €436m, 35% below last year.
20 Feb 17
Hayward Tyler Group* (HAYT): Trading update and financial position (CORP) | Petra Diamonds (PDL): Interim results (BUY) | Gemfields* (GEM): Interim results (CORP) | Premaitha Health* (NIPT): Middle East momentum (CORP) | Sound Energy (SOU): Acquisition update and TE-8 well spud (HOLD) | Proactis* (PHD): Interim trading on track (CORP) | 7digital* (7DIG): Automotive contract win (CORP)
The Slide Rule
12 Jan 17
What is The Slide Rule? The Slide Rule has been designed to dramatically simplify the identification of the best companies in the UK small/mid-cap sector by making a quantitative assessment of the relative potential of each company. At its core, The Slide Rule aims to identify those companies that create genuine shareholder value through strong returns on capital and solid growth, but also present a value opportunity with the potential tailwind of earnings momentum. Companies are assessed within a Quality, Value, Growth and Momentum (QVGM) framework.
Small Cap Breakfast
16 Feb 17
Saffron Energy—Schedule One update. Raising £2.5m, expected Mkt Cap £7.7m. Admission due 24 Feb. Italian Oil & Gas Play Guinness Oil & Gas Exploration—Publication of prospectus. Seeking to raise £50m and invest in 15 exploration companies at launch, with plans to grow the portfolio to 30 positions during its lifetime. Issue closing 23 Feb. Arix Bioscience — Intention to float on the main market from the global healthcare and life science Company supporting medical innovation. Raised £52m in Feb 16 with investors including Woodford Investment Management
Playing the long term, with short-term risks
16 Feb 17
After the publication of the annual results, we update our view and highlight the key points. Q4 16 key highlights As a reminder, the company reported results 30% below expectations at $400m for Q4 16. By division: 1) In upstream, underlying replacement costs profit came to $400m, vs. a loss a year earlier of $728m and a loss of $224m in Q3 16, reflecting the ongoing lower costs which have benefited from simplifications, efficiencies and lower exploration write-offs. In the US, the loss is still $147m. Production came in at 2.19mbpd, down 5.5% yoy due to disposals and up 1.8% on an underlying basis thanks to ramp-ups. One of the key events during the quarter was the renewal of BP’s onshore concession in the UAE with a 10% interest in the ADCO onshore oil concession. In terms of outlook, production should be higher in 2017 and will depend on the timing of project start-ups, acquisitions, divestments, and OPEC quota. Also the Abu Dhabi concession will be visible as from Q1 17. 2) In downstream, replacement costs profit came to $877m, down from $1.2bn a year ago and $1.4bn in Q3 16. The US division showed a loss of $371m vs a gain of $1.25bn. Non-US Fuel business earnings halved to $417m due to the weaker refining environment as well as the impact from the particularly large turnaround at the Whiting refinery. In lubricants, profit rose to $357m, reflecting the continued strong performance in its growth markets and premium brands as well as simplifications and greater efficiencies. The margin should remain unchanged for Q1 17. 3) Rosneft. Underlying replacement costs profit came to $135m, down from $235m a year ago, affected by the increased government take. Production was at 1.15mbpd, up from 1.03mbpd a year ago. This reflects the completion of the acquisition of Bashneft and Rosneft’s increased stake in the PetroMonagas venture. BP received a dividend of $322m after deduction of the withholding tax, in July 2016. On the Macondo oil spill, the charge taken for the Q4 16 pre-tax was $530m. This reflects BP’s latest estimates for claims including business economic loss. The pre-tax cash outflow on costs related to the oil spill for the full year 2016 was $7.1bn. Cash flow Excluding the Gulf of Mexico payment, the operating cash flow was $4.5bn. Underlying operating cash flow excluding the oil spill-related payment was $17.8bn for the full year. Proceeds during the year and the scrip dividend were not enough to cover capex and the cash dividend. Gearing at the end of the year increased to 27% ($35.5bn debt), in the high range of the group’s target of 20-30%. Organic capital was $16bn, below original guidance of $17bn to $19bn. Capex in 2017 should be close to $16-17bn. Divestment proceeds should be higher in 2017, close to $5bn and then reducing by $2-3bn per year after 2018. The total costs of the Deepwater payment should fall to $2bn in 2018 and then $1bn per year as from 2019. In 2017, this should be close to $5bn. All in all, including the latest acquisitions, cash flow break-even should be close to $60/bbl in 2017.
Share & share alike
14 Feb 17
The rally in the last fortnight, highlighted in the table, reflects a continued flow of positive updates and economic news. The FTSE 250, Small cap and Fledgling indices have reached record highs. We are in the lull ahead of results for those companies with a December year end, a welter of economic data regarding the UK economy, the State of the Union address in the US on 28 February and the UK Budget on Wednesday 8 March. We will learn at that stage the latest forecasts from the Office of Budget Responsibility. As highlighted previously, the reaction to corporate updates will continue to set the tone.
GMP FirstEnergy ― UK Energy morning research package
17 Feb 17
Enquest (ENQ LN): Speculative Buy, £0.65: Kraken FPSO in the field and hooked up in the North Sea | Ithaca Energy (IAE LN/CN)6: BUY, £1.40: Stella First Hydrocarbons in the North Sea | Bowleven (BLVN LN) (not covered): Denies claims made by Crown Ocean Capital